EXPRESSION OF THE TYROSINE KINASE RECEPTOR (EPHA1) IN THE EUTOPIC AND ECTOPIC ENDOMETRIUM OF PATIENTS WITH DEEP INFILTRATIVE ENDOMETRIOSIS USE OF MODERN DIGITAL TECHNOLOGIES

S. K. Muftaydinova, V. Chuprynin, Leonid Zakievich Fayzullin, N. A. Buralkina, Z. Muminova, A. Asaturova, Shohjakhon Khamdamov, Suxrobiddin Ismoilovich Abdullayev
{"title":"EXPRESSION OF THE TYROSINE KINASE RECEPTOR (EPHA1) IN THE EUTOPIC AND ECTOPIC ENDOMETRIUM OF PATIENTS WITH DEEP INFILTRATIVE ENDOMETRIOSIS USE OF MODERN DIGITAL TECHNOLOGIES","authors":"S. K. Muftaydinova, V. Chuprynin, Leonid Zakievich Fayzullin, N. A. Buralkina, Z. Muminova, A. Asaturova, Shohjakhon Khamdamov, Suxrobiddin Ismoilovich Abdullayev","doi":"10.1145/3584202.3584263","DOIUrl":null,"url":null,"abstract":"Objective of the study is to еvaluate the expression of EphA1 in the endometrium of healthy women, in eutopic and ectopic epithelial cells in deep infiltrative endometriosis. Used materials and methods such as IHC was carried out a comparative study of EphA1 expression in eutopic and ectopic endometrium in women with endometriosis depending on the type of endometriosis and in healthy women in different phases of the menstrual cycle. Have shown for the first time that in normal endometrium, a significantly higher expression of the EphA1 receptor on the surface of glandular cells is observed in the secretory phase of the menstrual cycle, compared with the proliferative one. In the eutopic endometrium of patients with DIE, a significantly increased level of EphA1 expression was found in both the proliferative and secretory phases of menstrual cycle compared with the group without endometriosis. The highest level of expression was detected in the foci of DIE (28.0 с.u. in the proliferative and 30.5 a.u. in the secretory phases). Indeed, overexpression of the EphA1 receptor in glandular cells of the eutopic and ectopic endometrium in patients with DIE makes them a perspicuous target for the development of new technologies for diagnosis and therapy in endometriosis.","PeriodicalId":438341,"journal":{"name":"Proceedings of the 6th International Conference on Future Networks & Distributed Systems","volume":"137 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the 6th International Conference on Future Networks & Distributed Systems","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1145/3584202.3584263","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective of the study is to еvaluate the expression of EphA1 in the endometrium of healthy women, in eutopic and ectopic epithelial cells in deep infiltrative endometriosis. Used materials and methods such as IHC was carried out a comparative study of EphA1 expression in eutopic and ectopic endometrium in women with endometriosis depending on the type of endometriosis and in healthy women in different phases of the menstrual cycle. Have shown for the first time that in normal endometrium, a significantly higher expression of the EphA1 receptor on the surface of glandular cells is observed in the secretory phase of the menstrual cycle, compared with the proliferative one. In the eutopic endometrium of patients with DIE, a significantly increased level of EphA1 expression was found in both the proliferative and secretory phases of menstrual cycle compared with the group without endometriosis. The highest level of expression was detected in the foci of DIE (28.0 с.u. in the proliferative and 30.5 a.u. in the secretory phases). Indeed, overexpression of the EphA1 receptor in glandular cells of the eutopic and ectopic endometrium in patients with DIE makes them a perspicuous target for the development of new technologies for diagnosis and therapy in endometriosis.
应用现代数字技术研究深浸润性子宫内膜异位症患者异位和异位子宫内膜中酪氨酸激酶受体(epha1)的表达
本研究的目的是评估EphA1在健康女性子宫内膜、深浸润性子宫内膜异位症中异位和异位上皮细胞中的表达。采用IHC等材料和方法,对不同类型子宫内膜异位症患者和不同月经周期健康女性中异位和异位子宫内膜中EphA1的表达进行了比较研究。首次发现在正常子宫内膜中,在月经周期的分泌期,EphA1受体在腺细胞表面的表达明显高于增殖期。在DIE患者的异位子宫内膜中,EphA1的表达水平在月经周期的增殖期和分泌期均明显高于未患子宫内膜异位症的患者。表达量最高的部位为DIE灶(28.0 μ u)。在增殖期和分泌期分别为30.5 a.u.)。事实上,EphA1受体在DIE患者异位和异位子宫内膜腺细胞中的过度表达,使其成为子宫内膜异位症诊断和治疗新技术开发的一个明显靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信